Diversifying preclinical research tools: expanding patient-derived models to address cancer health disparities
Trends in Cancer(2022)
Abstract
Cancer health disparities define a critical healthcare issue for racial/ethnic minorities in the USA. Key findings have led to cancer treatment improvements tailored to minority patients, but such successes have been rare. Here, we highlight how the use of patient-derived xenograft (PDX) and organoid models could resolve current blocks toward precision cancer health equity.
MoreTranslated text
Key words
PDX,PDO,GC,SEER,NCI,COSMIC,TCGA
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined